Drug Profile
LK 20286
Latest Information Update: 22 Aug 2007
Price :
$50
*
At a glance
- Originator LG Chem Investment
- Class Antibacterials; Quinolones
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 03 Aug 1998 No-Development-Reported for Bacterial infections in South Korea (Unknown route)
- 19 Jun 1995 Preclinical development for Bacterial infections in South Korea (Unknown route)